| |
Original Artikel |
Datum |
Titel |
Autoren Max. 6 Autoren |
| 1 |
[GO] |
2025―Mrz―06 |
Multiplicity of infection and culture medium on the SARS-CoV-2 virus like-particles production by baculovirus/insect system |
Luis Giovani de Oliveira Guardalini, Felipe Moura Dias, Samanta Omae Camalhonte, Jaci Leme, Thaissa Consoni Bernardino, Felipe Soares Sposito, Eduardo Dias, Renato Mancini Astray, Aldo Tonso, Soraia Attie Calil Jorge, Eutimio Gustavo Fernández Núñez |
| 2 |
[GO] |
2024―Aug―25 |
Amyloidogenesis of SARS-CoV-2 delta plus and omicron variants receptor-binding domain (RBD): impact of SUMO fusion tag |
Sadegh Zargan, Hasan Jalili, Bahareh Dabirmanesh, Saba Mesdaghinia, Khosro Khajeh |
| 3 |
[GO] |
2024―Jul―27 |
Plant production of recombinant antigens containing the receptor binding domain (RBD) of two SARS-CoV-2 variants |
Flavia Fagiani, Rachele Frigerio, Anna Maria Salzano, Andrea Scaloni, Carla Marusic, Marcello Donini |
| 4 |
[GO] |
2023―Mai―06 |
Multi-pathogen based chimeric vaccine to fight against COVID-19 and concomitant coinfections |
Rupal Ojha, Satyendra Singh, Nidhi Gupta, Ketan Kumar, Aditya K. Padhi, Vijay Kumar Prajapati |
| 5 |
[GO] |
2023―Mrz―13 |
Inactivation of SARS-CoV-2 variants by nitrogen-doped titanium dioxide loaded with metals as visible-light photocatalysts |
Takashi Matsuyama, Shu Saeki, Satoru Kosaka, Yoriko Matsuoka, Yoshifumi Aoki, Yasushi Itoh, Takao Imaeda |
| 6 |
[GO] |
2023―Jan―28 |
Enzymatic approaches against SARS-CoV-2 infection with an emphasis on the telomere-associated enzymes |
Alireza Valdiani, Hamideh Ofoghi |
| 7 |
[GO] |
2022―Nov―01 |
A gold nanoparticles-based lateral flow assay utilizing baculovirus expressed recombinant nucleocapsid and receptor binding domain proteins for serodetection of IgG and IgM against SARS-CoV-2 |
Reda Salem, Amany M. Elshamy, Noha Kamel, Soha Younes, Ohoud M. Marie, Fatma R. Waly, Alaa A. El-Kholy, Wael Elmenofy |
| 8 |
[GO] |
2022―Sep―26 |
High-yield production in Escherichia coli and convenient purification of a candidate vaccine against SARS-CoV-2 |
Giulia Maltoni, Lorenzo Scutteri, Francesca Mensitieri, Fabrizio Dal Piaz, Alejandro Hochkoeppler |
| 9 |
[GO] |
2022―Mai―24 |
A novel property of hexokinase inhibition by Favipiravir and proposed advantages over Molnupiravir and 2 Deoxy d glucose in treating COVID-19 |
Prajakta Kulkarni, Sriram Padmanabhan |
| 10 |
[GO] |
2022―Jan―19 |
Stem cells or their exosomes: which is preferred in COVID-19 treatment? |
Nashmin Fayazi Hosseini, Razieh Dalirfardouei, Mohammad Reza Aliramaei, Rezvan Najafi |
| 11 |
[GO] |
2022―Jan―17 |
Detection of homologous recombination events in SARS-CoV-2 |
Azadeh Lohrasbi-Nejad |
| 12 |
[GO] |
2021―Nov―27 |
Plant-derived VLP: a worthy platform to produce vaccine against SARS-CoV-2 |
Farshad Hemmati, Mohsen Hemmati-Dinarvand, Marziye Karimzade, Daria Rutkowska, Mohammad Hadi Eskandari, Sayyad Khanizadeh, Alireza Afsharifar |
